Addressing the Psychosocial Impact of Vitiligo: Enhancing Patient Support and Treatment Adherence
December 9th 2024The panelist discusses how vitiligo’s psychological and social impacts significantly affect patients’ quality of life and treatment adherence, necessitating a holistic approach that addresses both physical symptoms and psychosocial support needs.
Watch
Optimizing Access in Vitiligo Treatment: Managed Care Strategies for New Therapies
December 2nd 2024Seemal Desai, M.D., FAAD, discusses how managed care organizations can improve access to advanced vitiligo treatments through updated formulary decisions and treatment algorithms while addressing insurance coverage barriers and balancing treatment aggressiveness with value-based care considerations.
Watch
Optimizing Vitiligo Treatment: Safety, Efficacy and Special Population Consideration
November 25th 2024Seemal Desai, M.D., FAAD, discusses how treatment safety and effectiveness must be carefully evaluated through monitoring clinical outcomes and patient-reported measures, with special consideration given to unique challenges in vulnerable populations like children, pregnant women and those with comorbidities, where treatment approaches require careful modification to balance efficacy and safety concerns.
Watch
What the Trump Presidency Will Mean for U.S. Healthcare and Managed Care
November 22nd 2024This webinar on "What the Trump Presidency Will Mean for U.S. Healthcare and Managed Care" includes panelists Lindsay Greenleaf, J.D., MBA; Ryann Hill, M.P.H. and Patrick Cooney, discussing possible changes to healthcare policies and programs under the Trump administration, including the future of the Inflation Reduction and Affordable Care Acts, PBM reform and Medicare Advantage.
Watch
Key Clinical Considerations for Unique Patient Populations
November 22nd 2024Kenan R. Omurtag, M.D., discusses how addressing unique needs of LGBTQ patients involves tailored fertility treatments and legal considerations, while emphasizing the importance of early fertility preservation counseling and expedited procedures for cancer patients, including cryopreservation of eggs, sperm or embryos prior to potentially gonadotoxic treatments.
Watch
Role of Different Progesterone Injections in Leading to Successful Pregnancies
November 22nd 2024The panelist discusses how vaginal insert and intramuscular progesterone supplementation can support early pregnancy by enhancing endometrial receptivity, maintaining the uterine lining and providing crucial hormonal support during the luteal phase and early weeks of gestation, thereby potentially increasing the chances of successful implantation and ongoing pregnancy in assisted reproductive technology cycles.
Watch
Discussing Treatments to Stimulate Ovulation
November 22nd 2024Kenan R. Omurtag, M.D., discusses how various ovulation stimulation treatments, including letrozole and gonadotropins, work through different mechanisms to promote follicle development and egg release, with considerations such as efficacy, side effects and risk of multiple pregnancies influencing the choice of treatment for individual patients.
Watch
Exploring Emerging Therapies in Vitiligo
November 18th 2024The panelist discusses how emerging targeted therapies like Janus kinase inhibitors and combination treatment approaches are transforming vitiligo management, with treatment selection guided by disease patterns, progression rates and individual patient response, while acknowledging the need for systematic assessment and alternative strategies for treatment-resistant cases.
Watch
Examining the Role of Intracytoplasmic Sperm Injection
November 15th 2024The panelist discusses how intracytoplasmic sperm injection can be used in conjunction with in vitro fertilization (IVF) to directly inject a single sperm into an egg, thereby increasing fertilization rates and improving chances of successful pregnancy, particularly in cases of severe male factor infertility or previous IVF fertilization failure.
Watch
Exploring Best Practices for IVF
November 15th 2024Kenan R. Omurtag, M.D., discusses how less invasive fertility treatments like lifestyle modifications, ovulation induction and intrauterine insemination are typically attempted before progressing to IVF, which is often reserved for patients with severe male factor infertility, tubal factor infertility, advanced maternal age or those who have not succeeded with other fertility treatments.
Watch
Diagnostic Challenges and Treatment Impact in Vitiligo Management
November 11th 2024Seemal Desai, M.D., FAAD, discusses how immune system dysregulation and genetic variants intersect to trigger vitiligo development while highlighting diagnostic challenges including identifying disease subtypes and distinguishing vitiligo from other depigmentation disorders.
Watch
Describing Intrauterine Induction and Target Patient Populations
November 8th 2024The panelist discusses how intrauterine insemination is typically considered for patients with unexplained infertility, mild male factor infertility or cervical factor infertility, while emphasizing the importance of careful patient selection, timing of the procedure and monitoring for potential complications.
Watch
Background of Assisted Reproductive Technology
November 8th 2024Kenan R. Omurtag, M.D., discusses how assisted reproductive technology encompasses various medical procedures like in vitro fertilization, intracytoplasmic sperm injection and gamete donation to help individuals or couples struggling with infertility achieve pregnancy through manipulation of eggs, sperm or embryos outside the body.
Watch
Future Modalities for Infertility
November 1st 2024Lucy van de Wiel, PhD, discusses how emerging technologies such as in vitro gametogenesis and gene editing show promise for addressing complex infertility cases, potentially revolutionizing reproductive medicine by offering new solutions for patients with genetic disorders, same-sex couples, and those with uterine factor infertility.
Watch
Lucy van de Wiel, PhD, discusses how in vitro fertilization (IVF) has evolved since its first successful use in 1978, initially targeting women with blocked fallopian tubes but expanding to address various fertility issues, including male factor infertility, unexplained infertility and genetic disorders, while also becoming more accessible to diverse patient populations including same-sex couples and single individuals.
Watch
Impact of Infertility on Partners
November 1st 2024Lucy van de Wiel, PhD, discusses how infertility can strain relationships between partners by causing emotional distress, communication breakdowns, sexual difficulties and feelings of blame or inadequacy, potentially leading to conflicts and decreased relationship satisfaction.
Watch
Association of Infertility and Mental Health
October 25th 2024Lucy van de Wiel, PhD, discusses how infertility often leads to psychological distress and depression in patients, with stress potentially exacerbating fertility issues and creating a challenging cycle that can negatively impact conception efforts.
Watch
Key Clinical Information on Infertility
October 25th 2024Lucy van de Wiel, PhD, discusses how infertility is defined as the inability to conceive after 12 months of regular unprotected intercourse, diagnosed through medical history, physical exams and tests, with risk factors including age, lifestyle habits and medical conditions.
Watch
Optimizing the Management of TRD
Drs Steven Levine, Patricia Ares-Romero, Samuel Nordberg, Martin Rosenzweig, and Carrie Jardine share insight on the future treatment landscape for TRD.
Watch
Payer Strategies to Reduce Delay to TRD Therapy
Dr Martin Rosenzweig discusses the importance of data collection to improve patient care in TRD as well as alternative payment models.
Watch
Clinician Friendly Information Needed on Diseases Emerging Because of Climate Change | ID Week 2024
October 21st 2024University of Washington’s Peter Rabinowitz, M.D., M.P.H., sees a world awash in emerging diseases and climate change data but says it needs to be delivered to clinicians in a form that they can use at the point of care, possibly via the electronic medical record.
Watch
How Race Was Defined in the ELEVATUM Study | AAO 2024
October 19th 2024Patients self-identified as members of the minority group that the study was designed to enroll, according to Jeremiah Brown, M.D., of Retina Consultants of Texas, one of the lead ELEVATUM investigators. The study will yield a "treasure trove" of data, Brown said.
Watch
ELEVATUM Study's Reason to Be: Underrepresentation in Clinical Trials | AAO 2024
October 19th 2024Enrollment goals for the U.S. part of the phase 4, open-label study of Vabysmo (faricimab) were 45% Black participants, 45% Hispanic participants and 10% Native American, Pacific Islander and Native Hawaiian, said Jeremiah Brown, M.D., a lead ELEVATUM investigator.
Watch
Real-World Evidence of Apretude Highlights High Adherence, Effectiveness as PrEP | ID Week 2024
October 19th 2024Harmony Garges, M.D, senior vice president, chief medical officer and head of global medical at ViiV Healthcare, highlighted results of two real-world evidence studies of Apretude as an HIV prevention medication.
Watch
In the Real World, People Do Not Stick With GLP-1s for Weight Loss | AMCP Nexus 2024
October 18th 2024Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years later according to Prime Therapeutics’ real-world evidence, says Ben Urick, Pharm.D., Ph.D., a health outcomes researcher for the pharmacy benefit manager.
Watch